Of the biochemical parameters of glucose metabolism fasting insulin (NAFLD 129.46 ± 66.40 vs. non NAFLD 104.00 ± 46.58, p=0.08), fasting glucagon (NAFLD 14.20 ± 8.54 vs. non-NAFLD 10.36 ± 3.99, p=0.01) and HOMA-IR (NAFLD 4.41 ± 2.62 vs. non-NAFLD 3.32 ± 1.54, p=0.06) presented significant differences between the groups. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.